Whitehawk Therapeutics, Inc. Revenue 2018–2025
Whitehawk Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Whitehawk Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Whitehawk Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 7.1 M, a 71.08% decrease year-over-year.
- Whitehawk Therapeutics, Inc. annual revenue for 2025 was 7.1 M, a 72.50% decrease from 2024.
- Whitehawk Therapeutics, Inc. annual revenue for 2024 was 26.0 M, a 6.69% increase from 2023.
- Whitehawk Therapeutics, Inc. annual revenue for 2023 was 24.4 M, a 60.06% increase from 2022.
- Whitehawk Therapeutics, Inc. annual revenue for 2022 was 15.2 M.
Whitehawk Therapeutics, Inc. (WHWK) — Frequently Asked Questions
Whitehawk Therapeutics, Inc. (WHWK) is a publicly traded US company. It has a market capitalization of $251M. In fiscal 2025 it reported revenue of $7M and net income of -$21M. Explore WHWK's stock price, financial statements, earnings history, margins and key ratios below.
What is Whitehawk Therapeutics, Inc.'s market cap?
Whitehawk Therapeutics, Inc. (WHWK) has a market capitalization of $251M.
What is the WHWK stock price?
WHWK trades at $4.05 (+0.75% on the day).
How much revenue does Whitehawk Therapeutics, Inc. make?
Whitehawk Therapeutics, Inc. reported revenue of $7M in fiscal 2025.
Is WHWK profitable?
In fiscal 2025, Whitehawk Therapeutics, Inc. reported net income of -$21M.